A cost-effectiveness analysis of management strategies for cervical intraepithelial neoplasia grades 2 and 3

被引:17
作者
Kleinherg, MJ [1 ]
Straughn, JM [1 ]
Stringer, JSA [1 ]
Partridge, EE [1 ]
机构
[1] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL USA
关键词
cervical dysplasia; cost-effectiveness analysis;
D O I
10.1067/mob.2003.280
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: This study was performed to compare the cost-effectiveness of strategies for the management of cervical intraepithelial neoplasia, grades 2 and 3 (CIN 2 and CIN 3). STUDY DESIGN: A decision analysis compared six management strategies. The model was applied to hypothetic cohorts of 100,000 patients with CIN 2 and CIN 3. RESULTS: In both analyses, cryotherapy (CRYO) was the least expensive and least effective strategy; total vaginal hysterectomy was the most expensive and most effective strategy. For CIN 2, loop electrosurgical excision procedure (LEEP) was more effective than CRYO but at a cost of $31,437 per additional cure and $1.8 million per additional cancer prevented. For CIN 3, LEEP was more effective than CRYO, but at a cost of $17,592 per additional cure and $1.0 million per additional cancer prevented. CONCLUSION: CRYO is a cost-effective strategy that is appropriate in resource-poor settings. LEEP is also cost-effective, but the improved efficacy compared with CRYO comes at a significant cost. Total vaginal hysterectomy is very effective but is economically unsound because of excessively high costs.
引用
收藏
页码:1186 / 1188
页数:3
相关论文
共 10 条
[1]   Screening for cancer: Future potential [J].
Cuzick, J .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (05) :685-692
[2]  
Hamm RM, 1998, J FAM PRACTICE, V47, P193
[3]   DECISION-ANALYSIS FOR BEST MANAGEMENT OF MILDLY DYSKARYOTIC SMEAR [J].
JOHNSON, N ;
SUTTON, J ;
THORNTON, JG ;
LILFORD, RJ ;
JOHNSON, VA ;
PEEL, KR .
LANCET, 1993, 342 (8863) :91-96
[4]  
KOSS LG, 1963, CANCER, V16, P1160, DOI 10.1002/1097-0142(196309)16:9<1160::AID-CNCR2820160910>3.0.CO
[5]  
2-4
[6]  
Koutsky Laura, 1997, American Journal of Medicine, V102, P3
[7]  
OSTER AG, 1993, INT J GYNECOL PATHOL, V12, P186
[8]   The cost-effectiveness of treating women with a cervical vaginal smear diagnosis of atypical squamous cells of undetermined significance [J].
Raab, SS ;
Steiner, AL ;
Hornberger, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (02) :411-420
[9]   A DECISION-ANALYSIS OF PRACTICE PATTERNS USED IN EVALUATING AND TREATING ABNORMAL PAP SMEARS [J].
ROLAND, PY ;
NAUMANN, RW ;
ALVAREZ, RD ;
KILGORE, LC ;
PARTRIDGE, EE .
GYNECOLOGIC ONCOLOGY, 1995, 59 (01) :75-80
[10]   2001 consensus guidelines for the management of women with cervical cytological abnormalities [J].
Wright, TC ;
Cox, JT ;
Massad, LS ;
Twiggs, LB ;
Wilkinson, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (16) :2120-2129